Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
作者信息
Georgy Josh T, Jayakaran Jonathan A J, Jacob Anju S, Gunasekaran Karthik, Korula Pritish J, Devasia Anup J, Iyadurai Ramya
机构信息
Department of Medicine Unit V, Christian Medical College, Vellore, Tamil Nadu, India.
Department of Critical Care, Christian Medical College, Vellore, Tamil Nadu, India.
出版信息
J Med Virol. 2021 May;93(5):2642-2644. doi: 10.1002/jmv.26906. Epub 2021 Mar 9.
Abstract
摘要
相似文献
1
Evans syndrome and immune thrombocytopenia in two patients with COVID-19.两名新冠肺炎患者并发伊文氏综合征和免疫性血小板减少症。
J Med Virol. 2021 May;93(5):2642-2644. doi: 10.1002/jmv.26906. Epub 2021 Mar 9.
2
Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children.原发及继发免疫性血细胞减少症：儿童评估与治疗方法。
Hematol Oncol Clin North Am. 2019 Jun;33(3):489-506. doi: 10.1016/j.hoc.2019.01.005. Epub 2019 Mar 23.
3
Hematologic autoimmune disorders in the course of COVID-19: a systematic review of reported cases.COVID-19 相关血液系统自身免疫性疾病：已报告病例的系统回顾。
Hematology. 2021 Dec;26(1):225-239. doi: 10.1080/16078454.2021.1881225.
4
[Low thrombocyte count: when does it become dangerous?].[血小板计数低：何时会变得危险？]
MMW Fortschr Med. 2011 Oct 20;153(42):20-1. doi: 10.1007/BF03368928.
5
Immune Thrombocytopenia Secondary to COVID-19 Infection.新型冠状病毒肺炎感染继发免疫性血小板减少症
Isr Med Assoc J. 2021 Jun;23(6):342-343.
6
A case of Evans syndrome secondary to COVID-19.一例继发于新型冠状病毒肺炎的伊文氏综合征病例。
Blood Transfus. 2021 Jan;19(1):85-88. doi: 10.2450/2020.0221-20. Epub 2020 Dec 1.
7
Immune Thrombocytopenia Following the Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine.辉瑞-BioNTech BNT162b2 mRNA新冠疫苗接种后出现免疫性血小板减少症
Isr Med Assoc J. 2021 Jun;23(6):341.
8
[Evans syndrome as initial presentation of COVID-19 infection: A case report and review of the literature].[以埃文斯综合征为新冠病毒感染首发表现：一例病例报告及文献综述]
Ann Biol Clin (Paris). 2023 Mar 15;81(1):91-95. doi: 10.1684/abc.2023.1787.
9
SARS-CoV-2 infection in two pediatric patients with immune cytopenias: A single institution experience during the pandemic.两名患有免疫性血细胞减少症的儿科患者感染严重急性呼吸综合征冠状病毒2：大流行期间一家机构的经验
Pediatr Blood Cancer. 2020 Sep;67(9):e28503. doi: 10.1002/pbc.28503. Epub 2020 Jun 21.
10
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.新型冠状病毒肺炎相关免疫性血小板减少症的临床特征、管理及结局：一项法国多中心研究系列
Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4.
引用本文的文献
1
Evans Syndrome and COVID-19 Infection or Vaccination: A Systematic Review of Case Reports.伊文斯综合征与新冠病毒感染或疫苗接种：病例报告的系统评价
J Hematol. 2025 Jun;14(3):109-123. doi: 10.14740/jh2058. Epub 2025 May 13.
2
Combination of Evans syndrome and COVID-19: a systematic review of reported cases.伊文氏综合征与新型冠状病毒肺炎的合并症：已报告病例的系统评价
Blood Transfus. 2025 Jul-Aug;23(4):365-378. doi: 10.2450/BloodTransfus.860. Epub 2025 Feb 6.
3
SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports.SARS-CoV-2 感染诱导的免疫性血小板减少症：当前报告的系统综述。
Ann Hematol. 2024 Oct;103(10):3921-3939. doi: 10.1007/s00277-024-05765-1. Epub 2024 Apr 23.
4
Omicron-Induced Immune Thrombocytopenia: A Case Report.奥密克戎诱导的免疫性血小板减少症：一例报告
Cureus. 2023 May 29;15(5):e39648. doi: 10.7759/cureus.39648. eCollection 2023 May.
5
COVID-19-associated Evans syndrome: A case report and review of the literature.COVID-19 相关 Evans 综合征：病例报告及文献复习。
Transfus Apher Sci. 2022 Jun;61(3):103339. doi: 10.1016/j.transci.2021.103339. Epub 2021 Dec 7.
本文引用的文献
1
Heparin-Induced Thrombocytopenia in COVID-19.新型冠状病毒肺炎中的肝素诱导的血小板减少症
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620944091. doi: 10.1177/2324709620944091.
2
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.新型冠状病毒肺炎相关免疫性血小板减少症的临床特征、管理及结局：一项法国多中心研究系列
Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4.
3
Immune thrombocytopenia in a patient with COVID-19.新型冠状病毒肺炎患者的免疫性血小板减少症。
Int J Hematol. 2020 Dec;112(6):883-888. doi: 10.1007/s12185-020-02943-5. Epub 2020 Jul 16.
4
Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19.血小板减少症与因新冠肺炎住院患者的不良预后独立相关。
Br J Haematol. 2020 Sep;190(5):e276-e279. doi: 10.1111/bjh.16950. Epub 2020 Aug 31.
5
COVID-19 as a cause of immune thrombocytopenia.新型冠状病毒肺炎作为免疫性血小板减少症的一个病因
Med Mal Infect. 2020 Aug;50(5):459-460. doi: 10.1016/j.medmal.2020.05.003. Epub 2020 May 20.
6
Evans syndrome in a patient with COVID-19.一名新冠肺炎患者的伊文斯综合征
Br J Haematol. 2020 Jul;190(2):e59-e61. doi: 10.1111/bjh.16846. Epub 2020 Jun 18.
7
COVID-19-associated immune thrombocytopenia.新型冠状病毒肺炎相关免疫性血小板减少症
Br J Haematol. 2020 Jul;190(2):e61-e64. doi: 10.1111/bjh.16850. Epub 2020 Jun 8.
8
Autoimmune haemolytic anaemia associated with COVID-19 infection.与新型冠状病毒肺炎感染相关的自身免疫性溶血性贫血
Br J Haematol. 2020 Jul;190(1):29-31. doi: 10.1111/bjh.16794. Epub 2020 May 27.
9
Thrombocytopenia as an initial manifestation of COVID-19; case series and literature review.血小板减少作为新型冠状病毒肺炎的初始表现；病例系列及文献综述
Br J Haematol. 2020 Jun;189(6):1057-1058. doi: 10.1111/bjh.16769. Epub 2020 Jun 2.
10
Mechanism of thrombocytopenia in COVID-19 patients.新型冠状病毒肺炎患者血小板减少的机制。
Ann Hematol. 2020 Jun;99(6):1205-1208. doi: 10.1007/s00277-020-04019-0. Epub 2020 Apr 15.
Zotero 插件